A.R.T. Advisors, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$315,000
-65.5%
11,912
-78.4%
0.02%
-70.9%
Q1 2019$914,000
+25.2%
55,038
+44.4%
0.06%
+17.0%
Q4 2018$730,000
+7.0%
38,125
+192.2%
0.05%
+51.6%
Q3 2018$682,000
-32.4%
13,047
-43.8%
0.03%
-24.4%
Q2 2018$1,009,000
+134.1%
23,232
+99.5%
0.04%
+141.2%
Q1 2018$431,00011,6450.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders